Logo image of TWST

TWIST BIOSCIENCE CORP (TWST) Stock Fundamental Analysis

USA - NASDAQ:TWST - US90184D1000 - Common Stock

25.495 USD
-0.96 (-3.65%)
Last: 11/18/2025, 9:51:04 AM
Fundamental Rating

4

TWST gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 533 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for TWST as it has an excellent financial health rating, but there are worries on the profitability. TWST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year TWST has reported negative net income.
In the past year TWST has reported a negative cash flow from operations.
TWST had negative earnings in each of the past 5 years.
TWST had a negative operating cash flow in each of the past 5 years.
TWST Yearly Net Income VS EBIT VS OCF VS FCFTWST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.24%, TWST belongs to the top of the industry, outperforming 81.99% of the companies in the same industry.
The Return On Equity of TWST (-17.81%) is better than 85.74% of its industry peers.
Industry RankSector Rank
ROA -13.24%
ROE -17.81%
ROIC N/A
ROA(3y)-27.66%
ROA(5y)-27.95%
ROE(3y)-34.86%
ROE(5y)-34.47%
ROIC(3y)N/A
ROIC(5y)N/A
TWST Yearly ROA, ROE, ROICTWST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

TWST has a better Gross Margin (49.24%) than 75.61% of its industry peers.
TWST's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TWST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y27.06%
TWST Yearly Profit, Operating, Gross MarginsTWST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

7

2. Health

2.1 Basic Checks

TWST does not have a ROIC to compare to the WACC, probably because it is not profitable.
TWST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TWST Yearly Shares OutstandingTWST Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
TWST Yearly Total Debt VS Total AssetsTWST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 3.29 indicates that TWST is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.29, TWST is in the better half of the industry, outperforming 72.42% of the companies in the same industry.
TWST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.29
ROIC/WACCN/A
WACC8.78%
TWST Yearly LT Debt VS Equity VS FCFTWST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.90 indicates that TWST has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.90, TWST is in line with its industry, outperforming 46.34% of the companies in the same industry.
TWST has a Quick Ratio of 3.60. This indicates that TWST is financially healthy and has no problem in meeting its short term obligations.
TWST has a Quick ratio (3.60) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.9
Quick Ratio 3.6
TWST Yearly Current Assets VS Current LiabilitesTWST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.39% over the past year.
EPS 1Y (TTM)41.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.88%

3.2 Future

Based on estimates for the next years, TWST will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.90% on average per year.
Based on estimates for the next years, TWST will show a quite strong growth in Revenue. The Revenue will grow by 15.73% on average per year.
EPS Next Y26.72%
EPS Next 2Y17.7%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue Next Year16.18%
Revenue Next 2Y16.5%
Revenue Next 3Y15.69%
Revenue Next 5Y15.73%

3.3 Evolution

TWST Yearly Revenue VS EstimatesTWST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
TWST Yearly EPS VS EstimatesTWST Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TWST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TWST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TWST Price Earnings VS Forward Price EarningsTWST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TWST Per share dataTWST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

TWST's earnings are expected to grow with 12.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.7%
EPS Next 3Y12.9%

More info and screens

0

5. Dividend

5.1 Amount

TWST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TWIST BIOSCIENCE CORP

NASDAQ:TWST (11/18/2025, 9:51:04 AM)

25.495

-0.96 (-3.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)02-02 2026-02-02
Inst Owners115.89%
Inst Owner Change5.16%
Ins Owners1.33%
Ins Owner Change7.11%
Market Cap1.54B
Revenue(TTM)N/A
Net Income(TTM)-85.19M
Analysts83.75
Price Target39.59 (55.29%)
Short Float %17.8%
Short Ratio5.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.57%
Min EPS beat(2)-12.39%
Max EPS beat(2)17.53%
EPS beat(4)3
Avg EPS beat(4)10.46%
Min EPS beat(4)-12.39%
Max EPS beat(4)18.55%
EPS beat(8)6
Avg EPS beat(8)-2.76%
EPS beat(12)10
Avg EPS beat(12)7.02%
EPS beat(16)13
Avg EPS beat(16)8.07%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-1.11%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)1.03%
Revenue beat(8)6
Avg Revenue beat(8)1.66%
Revenue beat(12)8
Avg Revenue beat(12)1.45%
Revenue beat(16)12
Avg Revenue beat(16)2.28%
PT rev (1m)-4.97%
PT rev (3m)-11.2%
EPS NQ rev (1m)1.24%
EPS NQ rev (3m)4.31%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)33.19%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.25
P/FCF N/A
P/OCF N/A
P/B 3.22
P/tB 4.03
EV/EBITDA N/A
EPS(TTM)-2.11
EYN/A
EPS(NY)-1.55
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS6
BVpS7.92
TBVpS6.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.24%
ROE -17.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.24%
FCFM N/A
ROA(3y)-27.66%
ROA(5y)-27.95%
ROE(3y)-34.86%
ROE(5y)-34.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y27.06%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 68.92%
Cap/Sales 4.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.9
Quick Ratio 3.6
Altman-Z 3.29
F-Score5
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)242.63%
Cap/Depr(5y)230.64%
Cap/Sales(3y)21%
Cap/Sales(5y)18.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.73%
EPS Next Y26.72%
EPS Next 2Y17.7%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%16.88%
Revenue Next Year16.18%
Revenue Next 2Y16.5%
Revenue Next 3Y15.69%
Revenue Next 5Y15.73%
EBIT growth 1Y23.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year57.85%
EBIT Next 3Y23.42%
EBIT Next 5Y19.01%
FCF growth 1Y58.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.44%
OCF growth 3YN/A
OCF growth 5YN/A

TWIST BIOSCIENCE CORP / TWST FAQ

Can you provide the ChartMill fundamental rating for TWIST BIOSCIENCE CORP?

ChartMill assigns a fundamental rating of 4 / 10 to TWST.


What is the valuation status of TWIST BIOSCIENCE CORP (TWST) stock?

ChartMill assigns a valuation rating of 0 / 10 to TWIST BIOSCIENCE CORP (TWST). This can be considered as Overvalued.


How profitable is TWIST BIOSCIENCE CORP (TWST) stock?

TWIST BIOSCIENCE CORP (TWST) has a profitability rating of 3 / 10.


What is the earnings growth outlook for TWIST BIOSCIENCE CORP?

The Earnings per Share (EPS) of TWIST BIOSCIENCE CORP (TWST) is expected to grow by 26.72% in the next year.